New evidence suggests pipe and cigar smoking may be a more significant health risk than commonly perceived. A large analysis of US cohort studies reveals that pipe and cigar use is linked to accelerated lung function decline and higher risks of death and serious respiratory outcomes. These findings hold true even for individuals who have never smoked cigarettes.
The study analyzed data from over 22,000 adults, assessing lung function using spirometry. Compared to non-tobacco users, exclusive pipe and cigar smokers showed a faster annual decline in forced expiratory volume in one second (FEV1) and forced vital capacity. This reduction impacts airflow and lung volume, contributing to a gradual worsening of obstructive lung disease indicators.
Beyond lung function, pipe and cigar smoking was associated with a higher overall mortality risk and more than double the likelihood of hospitalization or death related to chronic obstructive pulmonary disease (COPD). These adverse outcomes were observed in individuals with no prior cigarette smoking history, underscoring the inherent risks of these tobacco products.
The findings challenge the perception that pipe and cigar smoking is a benign alternative. They emphasize the critical need for clinicians to inquire about all forms of tobacco use and support stronger public health initiatives targeting non-cigarette tobacco products.